
Bharti Airtel share: Motilal Oswal, Antique bullish; Avendus cautious
Shares of Bharti Airtel have drawn mixed reactions from leading brokerages following the company's Q1FY26 earnings, with some maintaining their bullish stance while others remain cautious amid competitive and capex-related concerns.
Motilal Oswal Financial Services (MOSL) has reaffirmed a 'Buy' rating on Bharti Airtel and raised its target price to ₹2,285 (from ₹2,200). The brokerage highlighted the telecom major's strong Q1 performance, robust free cash flows (FCF), and declining net debt. The stock has outperformed with a 22% gain calendar year-to-date versus a 4% rise in Nifty-50.
MOSL noted that valuation has been re-rated to ~12x FY27E EV/EBITDA, and further upside hinges on tariff hikes post-FY27. It is modeling 14%/17% CAGR in revenue/EBITDA over FY25–28.
Antique also retained a 'Buy' rating and raised its target price to ₹2,222 from ₹2,100. It said results were in line with expectations, with FY26/27 earnings expected to remain stable. While FY26 subscriber estimates were trimmed by 1%, the ARPU outlook was unchanged. A tariff hike in Q1FY27 could be the next key trigger. Lower wireless capex is expected to enhance FCF and RoE.
In contrast, Avendus retained a 'Reduce' call with a target price of ₹1,370, citing potential headwinds. It expects India capex (excluding Indus) at ₹28,500/₹27,500 crore for FY26/27, with increased spending in the Home & Enterprise segment. Free cash flow is forecast to rise significantly, from ₹23,300 crore in FY25 to ₹38,700 crore in FY27. However, rising capex from rivals VIL and BSNL could lead to some subscriber churn from the top two telcos, it warned.
Disclaimer: The views and investment suggestions expressed by brokerages are their own and not those of this publication. Investors are advised to consult certified financial experts before making any investment decisions.
Ahmedabad Plane Crash
Arunika Jain, a graduate in Mass Communication, brings a fresh perspective to the world of journalism. Arunika has a passion for writing finance and corporate news at BusinessUpturn.com. You can write to her at [email protected]
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
8 hours ago
- Business Upturn
Nifty top gainers and losers today, August 14: Wipro, Eternal, Infosys, HDFC Life among top performers
Indian equity markets ended marginally higher on August 14, with the Nifty holding above the 24,600 mark. At the close, the Sensex rose 57.75 points, or 0.07%, to 80,597.66, while the Nifty gained 11.95 points, or 0.05%, to settle at 24,631.30. Here's a look at Nifty top gainers and losers that drove the day's action (as per Trendline) for the day: Among the top gainers, Wipro emerged as the biggest performer, rising 2.1% to ₹246.8. Eternal followed with a 1.9% jump to ₹318.4, while Infosys advanced 1.5% to ₹1,448. HDFC Life Insurance gained 1.5% to ₹788, and Asian Paints added 1.1% to ₹2,528.7. Maruti Suzuki climbed 0.8% to ₹12,936, while State Bank of India and Eicher Motors each rose 0.6% to ₹826.6 and ₹5,746.5 respectively. HDFC Bank gained 0.6% to ₹1,991.1, and Titan Company closed 0.5% higher at ₹3,485. On the losers' side, Tata Steel was the biggest drag, slipping 3.1% to ₹155.3. Adani Ports dropped 1.4% to ₹1,301.4, and Tech Mahindra declined 1.3% to ₹1,486.7. Hero MotoCorp shed 1.3% to ₹4,708.1, while Bharat Electronics fell 1% to ₹384.9. Tata Consumer Products and Jio Financial Services each declined 1% to ₹1,045.4 and ₹327.4 respectively. ONGC slipped 0.9% to ₹236.6, UltraTech Cement eased 0.8% to ₹12,299, and HCL Technologies closed 0.8% lower at ₹1,489. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash EternalHDFC LifeInfosysWipro Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
14 hours ago
- Yahoo
Middle Eastern Penny Stocks: Gulf Pharmaceutical Industries P.S.C And Two More To Watch
The Middle Eastern stock markets have been experiencing mixed performances, with some indices buoyed by hopes of a U.S. Federal Reserve rate cut while others are weighed down by weaker corporate earnings. In this context, penny stocks—though an older term—remain relevant as they often represent smaller or less-established companies that can offer significant value when backed by strong financials. This article will highlight three such penny stocks in the Middle East, focusing on their potential for long-term growth and stability amidst current market conditions. Top 10 Penny Stocks In The Middle East Name Share Price Market Cap Financial Health Rating Big Tech 50 R&D-Limited Partnership (TASE:BIGT) ₪1.414 ₪15M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.71 SAR1.48B ★★★★★★ Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP) TRY4.75 TRY1.31B ★★★★★☆ E7 Group PJSC (ADX:E7) AED1.47 AED3B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY2.97 TRY3.2B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.45 AED392.7M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.89 AED12.25B ★★★★☆☆ Al Dhafra Insurance Company P.S.C (ADX:DHAFRA) AED4.86 AED486M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.828 AED488.43M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.937 ₪218.34M ★★★★★★ Click here to see the full list of 76 stocks from our Middle Eastern Penny Stocks screener. Here's a peek at a few of the choices from the screener. Gulf Pharmaceutical Industries P.S.C Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and internationally with a market cap of AED1.68 billion. Operations: The company's revenue segments include AED732.9 million from Planet and AED864.9 million from Manufacturing. Market Cap: AED1.68B Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown a positive shift in its financial performance, reporting a net income of AED 157.9 million for the first half of 2025 compared to a net loss the previous year. The company's debt is well-managed with operating cash flow covering 31.1% and a reduced debt-to-equity ratio from 117% to 55.9% over five years, indicating improved financial health. Despite low return on equity at 2.4%, Julphar's profitability and stable weekly volatility are promising traits for investors interested in Middle Eastern penny stocks with potential growth prospects amidst operational challenges. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Examine Gulf Pharmaceutical Industries P.S.C's earnings growth report to understand how analysts expect it to perform. Sinpas Gayrimenkul Yatirim Ortakligi Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat Anonim Sirketi in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates in the real estate sector with a market capitalization of TRY17.76 billion. Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion. Market Cap: TRY17.76B Sinpas Gayrimenkul Yatirim Ortakligi has demonstrated robust financial health, with short-term assets of TRY14.8 billion comfortably covering both its short and long-term liabilities. The company has experienced significant earnings growth, notably an 86.4% increase over the past year, surpassing industry averages. However, a substantial one-off gain of TRY5.3 billion skews recent earnings quality. While its net debt to equity ratio is satisfactorily low at 14.2%, interest coverage remains weak at 2.1 times EBIT, suggesting potential pressure in meeting debt obligations despite stable weekly volatility and reduced debt levels over five years. Unlock comprehensive insights into our analysis of Sinpas Gayrimenkul Yatirim Ortakligi stock in this financial health report. Review our historical performance report to gain insights into Sinpas Gayrimenkul Yatirim Ortakligi's track record. Oil Refineries Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.64 billion. Operations: Currently, there are no reported revenue segments for Oil Refineries Ltd. Market Cap: ₪2.64B Oil Refineries Ltd. faces challenges with a net loss of US$37 million in Q2 2025, contrasting with a profit last year. Despite this, its financial structure shows resilience; short-term assets of US$2 billion surpass both short and long-term liabilities. While the dividend yield is high at 10.22%, it isn't supported by earnings, raising sustainability concerns. Debt management has improved over five years, reducing from 127.7% to 75.3%. However, interest payments remain uncovered by EBIT and the company remains unprofitable despite shrinking losses annually by 25.8%. Management's experience offers some stability amid these hurdles. Dive into the specifics of Oil Refineries here with our thorough balance sheet health report. Explore historical data to track Oil Refineries' performance over time in our past results report. Turning Ideas Into Actions Click here to access our complete index of 76 Middle Eastern Penny Stocks. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ORL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@


Bloomberg
15 hours ago
- Bloomberg
Indian Investors Show Cautious Optimism Ahead of US-Russia Summit
Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at: Good morning, this is Chiranjivi Chakraborty, an equities reporter in Mumbai. There's not much to cheer for equity bulls on a rainy Thursday morning in Mumbai. Nifty futures are trading steady, and Asian markets haven't managed to sustain Wednesday's rally. The focus is shifting to the weekly expiry of Nifty options, especially with a long weekend ahead and a highly anticipated meeting between Donald Trump and Vladimir Putin. Meanwhile, foreign funds seem to be toning down their bearish bets. This, combined with still hopeful retail investors and domestic institutions sets the stage for a surprise move in the days ahead.